LONDON & BURLINGAME, Calif.--(BUSINESS WIRE)--GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) announced the US Food and Drug Administration (FDA) has approved a new indication ...
Add Yahoo as a preferred source to see more of our stories on Google. More than 15 million people in the U.S. are affected by COPD (chronic obstructive pulmonary disease), a condition that damages the ...
Rashelle Stocker was in third grade when she had her first asthma attack—a moment she remembers clearly even more than 30 years later. Playing tetherball on the playground with friends, she suddenly ...
Don’t Settle for Uncontrolled Symptoms: When It’s Time to Rethink Your Approach to Asthma Management
(BPT) – This content is sponsored by GSK. Those who live with asthma know that symptoms can come on suddenly, literally taking your breath away. Even if you’re avoiding triggers and following your ...
Use with caution in patients with prostatic hyperplasia or bladder-neck obstruction and instruct patients to contact a healthcare provider immediately if symptoms occur. Use Trelegy Ellipta with ...
Don’t Settle for Uncontrolled Symptoms: When It’s Time to Rethink Your Approach to Asthma Management
(BPT) – This content is sponsored by GSK. Those who live with asthma know that symptoms can come on suddenly, literally taking your breath away. Even if you’re avoiding triggers and following your ...
New asthma indication for Trelegy Ellipta introduces an important option for patients to the current treatment paradigm The FDA-approved strength for both COPD and asthma is fluticasone furoate / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results